Evidence map›Paper›PMID 31438749›Full record

ArticleThe Journal of international medical research2019

An impaired glucagon-like peptide-1 response is associated with prediabetes in polycystic ovary syndrome with obesity.

Simona Ferjan, Mojca Jensterle, Tjasa Oblak, Irena Prodan Zitnik, Janja Marc, Katja Goricar, Vita Dolzan, Andrej Janez

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of international medical research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Proglucagon-Derived Peptides as Therapeutics.Frontiers in endocrinology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Simona FerjanDepartment of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre, SI-1000 Ljubljana, Slovenia.ORCID https://orcid.org/0000-0002-7864-395X
Mojca JensterleDepartment of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre, SI-1000 Ljubljana, Slovenia.
Tjasa OblakUniversity of Ljubljana Faculty of Medicine, SI-1000 Ljubljana, Slovenia.
Irena Prodan ZitnikUniversity of Ljubljana Faculty of Pharmacy, SI-1000 Ljubljana, Slovenia.
Janja MarcUniversity of Ljubljana Faculty of Pharmacy, SI-1000 Ljubljana, Slovenia.
Katja GoricarUniversity of Ljubljana, Faculty of Medicine, Institute of Biochemistry, Pharmacogenetics Laboratory, SI-1000 Ljubljana, Slovenia.
Vita DolzanUniversity of Ljubljana, Faculty of Medicine, Institute of Biochemistry, Pharmacogenetics Laboratory, SI-1000 Ljubljana, Slovenia.
Andrej JanezDepartment of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre, SI-1000 Ljubljana, Slovenia.
University of Ljubljana · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultFemaleGlucagon-Like Peptide 1Glucose Tolerance TestHumansIncretinsObesityPolycystic Ovary SyndromePrediabetic StateGlucagon-Like Peptide 1Incretinsglucagon-like peptide-1 (GLP-1) responseinsulinnormal glucose toleranceobesitypolycystic ovary syndromePrediabetes

Identifiers

PMID31438749
PMCPMC6833370
OpenAlexW2969609279

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.